The worst side effects of Cymbalta (duloxetine) range from increased suicidal thoughts in young people to liver damage, serotonin syndrome, and severe skin reactions. Most people tolerate the drug without experiencing these serious effects, but they are real risks that the FDA has flagged through warnings and label changes. Beyond the rare but dangerous reactions, Cymbalta also causes a set of deeply disruptive everyday side effects, including sexual dysfunction and withdrawal symptoms that can last weeks or months.
Increased Suicide Risk in Young People
Cymbalta carries the FDA’s most serious warning, a black box label, for increased suicidal thinking and behavior in children and adolescents. A combined analysis of short-term trials (up to four months) across nine antidepressant drugs found that 4% of young patients on medication experienced suicidal thoughts or behavior, compared to 2% on placebo. That means the risk roughly doubled.
This risk is highest during the first few months of treatment and whenever the dose changes, whether it goes up or down. Warning signs include agitation, irritability, unusual behavior changes, and restlessness. The black box warning applies to all antidepressants, not just Cymbalta, but it remains one of the most important safety considerations for younger patients starting the drug.
Liver Damage
Cymbalta can stress the liver, particularly in people who drink alcohol. In clinical trials, about 10.6% of patients on duloxetine showed abnormal liver enzyme levels on blood tests, compared to 7.7% on placebo. While that’s a relatively modest difference for most people, a small number of trial participants developed liver enzyme levels more than ten times the normal upper limit, a sign of significant liver injury.
Three men in clinical trials developed jaundice or other signs of serious liver problems alongside abnormal enzymes, and all three had a history of alcohol use. No liver transplants or deaths from liver failure occurred in trials, but FDA reviewers concluded the risk couldn’t be ruled out and recommended that Cymbalta not be prescribed to anyone who drinks heavily or has a history of alcohol abuse. If you have pre-existing liver disease, your doctor will likely monitor your liver enzymes regularly during the first several months of treatment.
Serotonin Syndrome
Serotonin syndrome is a potentially life-threatening reaction that happens when too much serotonin builds up in the body. Because Cymbalta works by increasing serotonin levels, the risk climbs significantly when it’s combined with other drugs that do the same thing. That includes common medications like migraine triptans, opioid painkillers (tramadol, fentanyl, oxycodone), over-the-counter cough medicines containing dextromethorphan, and supplements like St. John’s wort.
Symptoms usually appear within hours of starting a new drug or increasing a dose. Mild cases involve agitation, rapid heart rate, heavy sweating, diarrhea, and muscle twitching. Severe serotonin syndrome causes high fever, seizures, irregular heartbeat, muscle rigidity, and loss of consciousness. It requires emergency treatment. The single most dangerous combination is Cymbalta with an MAO inhibitor antidepressant, which is why there’s a mandatory waiting period between stopping one and starting the other.
Severe Skin Reactions
Cymbalta has been linked to Stevens-Johnson syndrome, a rare but serious condition where the skin blisters and peels as if burned. It can also affect the mucous membranes of the mouth, eyes, and genitals. The FDA’s postmarketing surveillance identified cases of both Stevens-Johnson syndrome and a related condition called erythema multiforme in patients taking Cymbalta. The labeling now states that Cymbalta should be stopped immediately at the first sign of blisters, peeling rash, or mucosal erosions if no other cause can be found.
Sexual Dysfunction
Sexual side effects are among the most common reasons people stop taking antidepressants, and Cymbalta is no exception. In research on antidepressant compliance, 20% of patients reported loss of interest in sex and 20% reported inability to orgasm as reasons they stopped taking their medication. Among men, 25% reported erectile problems, and 24% reported difficulty reaching orgasm. Patients rated these effects as “extremely difficult to live with.”
What makes sexual side effects particularly frustrating is that they often persist for as long as you take the drug. Unlike nausea or dizziness, which tend to fade after the first few weeks, sexual dysfunction typically doesn’t resolve on its own at a given dose.
Blood Pressure Changes
Cymbalta raises blood pressure by a small but measurable amount. At standard doses, clinical trials found a mean increase of up to 2.1 mmHg in systolic pressure and 2.3 mmHg in diastolic pressure. For most people, that’s clinically insignificant. But if you already have high blood pressure or are on the borderline, even a small sustained increase can matter over time. Your blood pressure should be checked before starting Cymbalta and monitored periodically afterward.
Withdrawal and Discontinuation Symptoms
Cymbalta has a reputation for being one of the harder antidepressants to stop taking, and that reputation is deserved. Stopping abruptly can trigger a cluster of withdrawal symptoms: nausea, headache, dizziness, anxiety, irritability, and the sensation many patients describe as “brain zaps,” brief electric shock-like feelings in the head. These symptoms can last anywhere from a few days to several weeks, and in some cases, months.
The short half-life of Cymbalta (the drug clears your system relatively quickly) is part of the problem. Even missing a single dose can trigger mild withdrawal in some people. Tapering slowly under medical supervision is the standard approach, but Cymbalta’s capsule design makes fine-tuned dose reductions difficult compared to medications available in smaller increments. This is one of the drug’s most commonly reported frustrations and something worth discussing before you start taking it.
Weight Changes
Cymbalta has a somewhat unusual pattern when it comes to weight. In the short term, many people actually lose a small amount of weight. Over longer treatment periods, that reverses. In a 34-week trial, patients on the standard dose gained an average of 0.7 kg (about 1.5 pounds) compared to 0.1 kg on placebo. At higher doses, the gain was slightly more, averaging 0.9 kg. A year-long open-label study found an average weight gain of 1.1 kg (roughly 2.4 pounds) at the end of treatment. That’s modest compared to some other antidepressants, but it’s not weight-neutral.
Urinary Retention
About 1% of patients on Cymbalta experience difficulty emptying their bladder. The drug strengthens the muscle that keeps the urethra closed, which is actually why it’s sometimes prescribed for stress urinary incontinence. But in some people, that same mechanism goes too far, making it hard to urinate normally. This is more likely to be a problem for people who already have urinary issues or an enlarged prostate, and it can require stopping the medication to resolve.